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Sendai virus (SeV) is unique in that one of the viral accessory proteins, C, enhances budding of virus-like particles (VLPs) formed by SeV
matrix protein M by physically interacting with Alix/AIP1. C protein itself does not have the ability to form VLPs, while M protein provides viral
budding force, like other enveloped viruses. Here we show that SeV C protein recruits Alix/AIP1 to the plasma membrane (PM) to facilitate VLP
budding. SeV M-VLP budding is sensitive to overexpression of a dominant-negative (DN) form of VPS4A only in the presence of the C proteins,
which is able to recruit Alix/AIP1 to the PM. Our results indicate that SeV M and C proteins play separate roles in the budding process: M protein
drives budding and C protein enhances the efficiency of the utilization of cellular MVB sorting machinery for efficient VLP budding.
© 2007 Elsevier Inc. All rights reserved.Keywords: Paramyxovirus; Sendai virus; Virus-like particles; Budding; C protein; Alix/AIP1; MVB sortingIntroduction
Since enveloped viruses bud from cellular membranes to
acquire lipid-containing envelopes, membrane fission event is
essential for them to be efficiently released from host cells at the
final step of their lifecycle. Viral matrix and retroviral Gag proteins
have been shown to be able to bud from the cell surface by
themselves in the form of lipid-enveloped, virus-like particles
(VLPs), suggesting that these proteins play important roles in the
late-budding step (Bieniasz, 2006). Formany enveloped viruses, it
has been shown that host cell endosomal sorting machinery is
utilized for efficient virus budding (Bieniasz, 2006). This is
achieved through an interaction between late-budding (L) domains
identified within the viral matrix and Gag proteins and a
component of host cellular protein trafficking machinery (Bien-
iasz, 2006). The major L-domain motifs, PPxY, PT/SAP, YPxL,
and/or LxxL have been identified, and have been especially well
characterized in retroviruses (Demirov and Freed, 2004; Fisher
et al., 2007; Strack et al., 2003). The PPxY-, PT/SAP-, and YPxL/
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(Tsg101), a member of ESCRT-I (endosomal sorting complex
required for transport I), and Alix/AIP1, which has been reported
to be linked to ESCRT-I and -III complexes (Demirov and Freed,
2004).
ESCRT complexes play a critical role in sorting proteins into
the multivesicular body (MVB) in mammalian cells (Slagsvold
et al., 2006). In this process, three ESCRTcomplexes, ESCRT-I,
-II, and -III act in a sequential manner (Babst et al., 2002a,b). In
the final step of protein sorting, an AAA-type ATPase VPS4
interacts with ESCRT-III to catalyze the disassembly of ESCRT
machinery to recycle its components (Babst et al., 1997, 1998).
Since the expression of dominant-negative (DN) forms of VPS4
lacking the ability to bind or hydrolyze ATPwas shown, in many
cases, to inhibit the budding of VLPs and/or viruses containing
any of the major three types of L-domains, it is believed that
most viruses possessing these L-domain motifs generally utilize
MVB sorting machinery for efficient budding (Bieniasz, 2006).
However, for many other enveloped viruses, L-domain motifs
have not yet been identified, and whether MVB sorting
machinery is involved in the virus budding is still unknown.
Recently, in addition to the major L-domain motifs, FPIV, YEIL,
and YMYL motifs have been identified as potential L-domains
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Gag, and Nipah virus M proteins, respectively (Ciancanelli and
Basler, 2006; Patton et al., 2005; Schmitt et al., 2005). However,
the interacting partners of these motifs have not been identified
yet. In addition, it should be noted that SV5Mprotein alone does
not have the ability to bud as VLPs and requires other viral
proteins for efficient budding (Schmitt et al., 2002).
As for SeV, a prototype of the family Paramyxoviridae, we
recently reported that the YLDL motif within M protein is
critical for M-VLP budding and physically and functionally
interacts with Alix/AIP1 (Irie et al., 2007). In addition, SeV is
unique in that one of the viral accessory proteins, C, also
physically interacts with Alix/AIP1 in a different manner from
the M-Alix/AIP1-interaction, and enhances M-VLP budding,
although C protein does not have the ability to form VLPs (Irie
et al., 2007; Sakaguchi et al., 2005).
SeVC protein is translated from the −1 reading frame relative
to the P gene frame. P protein is initiated at the AUG codon at
position 104, whereas four C proteins, C', C, Y1, and Y2, are
produced from the initiation codons at positions 81, 114, 183,
and 201, respectively (Lamb and Parks, 2006). C proteins are
multifunctional proteins involved in regulation of viral RNA
synthesis (Curran et al., 1992; Grogan and Moyer, 2001;
Horikami et al., 1997), counteracting the innate immune
response of the host cell (Garcin et al., 2001, 1999; Gotoh
et al., 2003; Kato et al., 2001; Komatsu et al., 2002; Takeuchi
et al., 2001), inhibition of virus-induced apoptosis (Koyama
et al., 2003), and the efficiency of VLP/virus budding (Irie et al.,
2007; Sakaguchi et al., 2005; Sugahara et al., 2004). Recently, it
was reported that the unmodified N-terminal 23 amino acids of
SeV C protein function as a PM targeting signal and a membrane
anchor based on experiments using artificial recombinant
C proteins containing reporter tdTomato fluorescent protein,
and that localization of C protein at the PM is important for its
ability to induce phosphorylated-Stat1 formation in an IFN-
independent manner (Marq et al., 2007).
In this report, we show that localization of C protein at the
PM is also important for its ability to enhance M-VLP budding,
and we discuss a possible mechanism for this enhancement.
Results
The N-terminal 23 amino acids of SeV C protein are important
for its ability to localize to the PM
Recently, it has been reported that the unmodified N-terminal
23 amino acids of SeV C protein functions as a PM targeting
signal and a membrane anchor, as shown by studies using
artificial recombinant C proteins containing reporter tdTomato
fluorescent protein (Marq et al., 2007). To examine this ability
of the intact C protein without any influence of smaller C
proteins synthesized from the downstream initiation codons, we
constructed a series of C protein mutants in which the initiation
codons for Y1 and/or Y2 were replaced by ACG, resulting in
amino acid changes of methionine to threonine (Fig. 1A). In
addition, three C-terminal deletion mutants were constructed in
the C-d2Y backbone (Fig. 1A).At first, the cellular localization of these C mutants was
analyzed by immunofluorescence microscopy using anti-C pAb
(Fig. 1B). As expected from the recent report by Marq et al.
(2007), in the C-WT-transfected cells where smaller amounts of
Y1 and Y2 as well as C proteins were produced, fluorescence was
predominantly detected at the cell periphery; intracellular
membranes and cytosol were hardly fluorescent (Fig. 1B, upper
left). Predominant localization of the fluorescence at the PM was
also observed in the C-dY1 and C-d2Y-transfected cells lacking
Y1 and both Y1 and Y2 protein expression, respectively (Fig. 1B,
middle left and right). Interestingly, in addition to the localization
at the cell periphery, weaker fluorescence was detected at the
nuclear envelope in the C-dY2-transfected cells where C and Y1
proteins were produced (Fig. 1B, middle). In the C-terminal
deletion mutant-transfected cells, fluorescence was still mainly
observed at the cell periphery, although localization probably at
intracellular membranes and granular distribution throughout the
cytoplasm appeared in accordance with the length of the C-
terminal deletion (Fig. 1B, bottom left, and data not shown). In
contrast to these C mutants, diffuse cytoplasmic and nuclear
localization was observed in the Y1-transfected cells where Y2 as
well as Y1 proteins were produced, but localization at the PMwas
not detectable (Fig. 1B, upper middle). In some of the Y1-
transfected cells, fluorescence was predominantly detected in the
nucleus (Fig. 1B, upper right). Similar subcellular localization
was observed in the Y1-dY2-transfected cells where only Y1
protein was produced and in the Y2-transfected cells (Fig. 1B,
bottom middle and bottom right).
The localization of these C mutants was also examined by
subcellular fractionation (Figs. 1C and D). Cytosolic (S) and
membrane (P) fractions were prepared from the post-nuclear
supernatant (PNS) of C mutant-transfected 293T cells, and the
protein expression in equal amounts of each sample was
compared by Western blotting using anti-C pAb followed by
quantitative analysis using an LAS-1000 luminescent image
analyzer. SeV HN-transfected samples served as a control for
membrane-targeted proteins. As expected, most of the HN
protein was detected in the membrane fraction and almost none
in the cytosolic fraction (Figs. 1C, lanes 21 and 22, and D). In
accord with the results of Fig. 1B, C-WT as well as all of the C
mutants retaining an intact N-terminus were predominantly
detected in the membrane fractions, with membrane to cytosolic
ratios ranging from approximately 11 to 26 (Figs. 1C, lanes 1–
14, and D). In contrast, similar amounts of Y1, Y1-dY2, and Y2
proteins were detected in the cytosolic and membrane fractions
(Figs. 1C, lanes 15–20, and D).
These results indicate that the N-terminal 23 amino acid
region of SeV C protein was important for its ability to associate
with the PM, and that the additional expression of Y1 and/or Y2
proteins from downstream AUG codons of the transfected-C
mutants was not required for this ability.
Localization of SeV C protein at the PM is important for its
ability to enhance SeV M-VLP budding
Budding of SeV and SeV VLPs occurs at the PM, and we
previously reported that SeV C protein could enhance M-VLP
Fig. 1. Subcellular distributions of SeV C proteins. (A) Schematic representation of expression plasmids encoding C-WT, C-dY1, C-dY2, C-d2Y, C-d2Y-d192, C-d2Y-
d188, C-d2Y-d184, Y1, Y1-dY2, and Y2. (B) C proteins were expressed in 293T cells. At 24 h p.t., cells were fixed with 3% formaldehyde, permeabilized with 0.1%
Triton X-100, and stained with anti-C pAb and Alexa 488-conjugated anti-rabbit IgG antibody as primary and secondary antibodies, respectively. Cells were observed
under a Zeiss LSM5 confocal microscope. The lower panels represent orthogonal views of the cells reconstituted from 20 slices. Bars, 10 μm. (C) C proteins were
expressed in 293T cells, and cells were harvested at 24 h p.t. Cytosolic (S) and membrane fractions (P) were prepared from the PNS as described in Materials and
methods, and equal amounts of each sample were separated by SDS-PAGE, and analyzed by Western blotting using anti-C pAb. A transmembrane protein, SeV
hemagglutinin-neuraminidase (HN), was used as a control. (D) C proteins in the cytosolic and membrane fractions were quantitated using an LAS-1000 luminescent
image analyzer. Ratios of the amounts of each C protein in the membrane fractions to those in the cytosolic fractions are shown.
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et al., 2004). We next sought to determine whether the targeting
of SeV C protein to the PM was important for this enhancement
of budding. For this purpose, we first examined SeV M-VLP
budding in the presence of the C mutants using a functional
budding assay (Fig. 2). 293T cells were transfected with M-WT
plasmid together with the designated C mutants. Almost iden-
tical amounts of M protein were expressed in transfected
cells (Fig. 2A, lanes 13–22), and the expression of the C mu-
tants was confirmed (Fig. 2A, lanes 25–33). Quantitation of
the average amounts of radioactivity revealed that, consistently
with our previous results (Sakaguchi et al., 2005), budding ofSeV M-VLP was enhanced approximately 5-fold in the C-WT-
transfected cells where C, Y1, as well as Y2 proteins were
produced (Figs. 2A, lane 3, and B), although additional viral
proteins, HN, F, and N, were not present, unlike in our previous
report (Sakaguchi et al., 2005). Similar enhancement was also
observed in the C-dY1-, C-dY2-, and C-d2Y-transfected cells
where C and Y2, C and Y1, and C protein alone were expressed,
respectively (Figs. 2A, lanes 4–6, and B). As expected from our
previous results (Sakaguchi et al., 2005), such enhancement was
not observed in the C-d2Y-d192, C-d2Y-d188, or C-d2Y-d184-
transfected cells, where only the C-terminally-deleted C pro-
teins but not Y1 and Y2 proteins were produced (Figs. 2A, lanes
Fig. 2. Budding assay of SeVM-VLP in the presence of Cmutants. (A) 293Tcells
were co-transfected with SeV M and the indicated C mutants. At 24 h p.t., cells
were radio-labeled for another 6 h.Cell lysates andVLPswere immunoprecipitated
with anti-SeV pAb for M protein and anti-C pAb for C mutants. (B) M proteins
present in VLPs and cell lysates were quantitated. Budding rates were calculated as
described in Materials and methods, and that from cells transfected with an empty
vector (−) was set to 1. Bars represent the average from at least three independent
experiments.
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and Y2, or Y1 alone were produced, budding of SeV M-VLP
was not essentially enhanced (Figs. 2A, lanes 10 and 11, and B).
These results indicate that expression of the additional smaller
Y1 and Y2 proteins is not required for the ability of the C
protein to enhance SeV M-VLP budding, and that both the C-
and N-terminal regions are important for this ability.
Since N-terminal deletion results in the loss of membrane
association of the C protein (Fig. 1), the lack of ability of Y1 and
Y1-dY2 proteins to enhance SeV M-VLP budding might have
been due to their loss of targeting to the PM. To examine this
possibility, the K-Ras CAAX domain, which is known to mediate
PM association, were fused to the C-termini of C-d2YandY1-dY2.
Three modified CAAX domains, 6KCVIM (KKKKKKCVIM),
12KCVIM (KKKKKKKKKKKKCVIM), and 6(KR)CVIM (KR-
KRKRKRKRKRCVIM), were chosen by referring to the pre-
vious report by Welman et al. (2000), and Y1-dY2-6KCVIM,
-12KCVIM, and -6(KR)CVIM were generated (Fig. 3A). In the
IFA study, fluorescence was observed at the PM and intracellular
membrane structures in the cells transfected with any of these
recombinants, unlike the fluorescence observed in theY1 andY1-dY2-tranfected cells where fluorescence was observed diffusely
in the cytoplasm and the nucleus, although nuclear localization
was still observed (Fig. 3B, middle, and data not shown). We
decided to use Y1-dY2-6KCVIM for further experiments, be-
cause its PM localizationwasmost predominant among these Y1-
dY2-CAAX constructs (data not shown). We also introduced the
modified 6KCVIM-type CAAX domain to the C-terminus of C-
d2Y to generate C-d2Y-6KCVIM (Fig. 3A). In the IFA study,
predominant PM localization was observed in cells transfected
with this construct, like that observed in the cells transfected with
C-d2Y and the other C mutants containing no N-terminal dele-
tions (Fig. 3B, left). Furthermore, to examine whether the
introduction of a heterologous Alix/AIP1-binding motif into the
C-terminally-deleted C protein recombinants would recover the
ability of budding enhancement, we generated C9 construct, in
which an Alix/AIP1-interacting motif-containing region from
EIAV p9Gag was fused to the N-terminus of the C-d2Y-d192
construct (Fig. 3A). In the IFA study, predominant PM localization
was observed in the cells transfected with C9, like that observed in
the cells transfected with the C-terminally-deleted C-d2Y-d192
(Fig. 3B, right). Predominant localization of the C-d2Y-6KCVIM,
Y1-dY2-6KCVIM, and C9 proteins at the membrane was also
confirmed by the subcellular fractionation analysis (Fig. 3C).
The effect of these recombinants on SeV M-VLP budding
was also examined (Fig. 3D). Almost identical amounts of M
protein were expressed in transfected cells (Fig. 3D, lanes 9–11
and 13–14), and the expression of the C mutants was confirmed
(Fig. 3D, lanes 17, 18, and 21). Quantitation of the data revealed
that budding of SeV M-VLP was enhanced approximately 5.5-
fold in the presence of C-d2Y-6CVIM (compare bar graphs of
Figs. 2 and 3D). Interestingly, enhancement of SeV M-VLP
budding was also observed in the presence of Y1-dY2-6KCVIM
and C9, although Y1-dY2 and C-d2Y-d192 failed to increase the
budding efficiency (compare bar graphs of Figs. 2 and 3D).
These results indicate that the ability of SeV C protein to
mediate PM association is important for its ability to enhance SeV
M-VLP budding, and that the ability of budding enhancement can
be recovered by the introduction of an Alix/AIP1-binding motif
into the C-terminally-deleted C-d2Y-d192.
Alix/AIP1 is recruited to the PM by membrane-associating and
Alix/AIP1-interacting C proteins
Since we previously reported that enhancement of SeVM-VLP
budding byC protein correlates with SeVC-Alix/AIP1-interaction
(Sakaguchi et al., 2005), the interaction of ourCmutantswithAlix/
AIP1 was examined (Figs. 4 and 5). The interaction was first
examined by co-immunoprecipitation analysis (Fig. 4). 293T cells
were co-transfected with the indicated C mutants together with
Alix/AIP1 and radio-labeled. For the C-terminal deletion mutants,
C-d2Y-d192, -d188, and -d184, the interaction was examined by
IP-Western blotting, because they were less efficiently radio-
labeled probably due to their lower stability (Fig. 4B, and data not
shown). Expression of adequate amounts of Alix/AIP1 and the C
mutants was confirmed (Figs. 4A, lanes 1–24, and B, lanes 5–12).
As expected from our previous results (Sakaguchi et al., 2005),
Alix/AIP1 was co-immunoprecipitated with the C mutants, which
Fig. 3. Characteristics of the C mutants C-terminally fused with modified CAAX domains from K-Ras and Alix/AIP1-binding motif-containing region from EIAV p9
Gag. (A) Schematic representation of expression plasmids encoding C-d2Y-6KCVIM, Y1-dY2-6KCVIM, Y1-dY2-12KCVIM, Y1-dY2-6(KR)CVIM, and C9.
(B) The indicated C mutants were subjected to immunofluorescence microscopy as shown in Fig. 1B. The lower panels represent orthogonal views of the cells
reconstituted from 20 slices. Bars, 10 μm. (C) The mutant proteins present in the cytosolic and membrane fractions were analyzed by Western blotting as shown in
Figs. 1C and D. (D) Budding assay of SeVM-VLPs in the presence of these C mutants. 293T cells co-transfected with SeVM and the indicated C mutants were radio-
labeled, and analyzed as shown in Fig. 2. M proteins present in VLPs and cell lysates were quantitated. Budding rates were calculated as described in Materials and
methods, and that from cells transfected with an empty vector (−) was set to 1. Bars represent the average from three independent experiments.
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regardless of the presence or absence of the expression of
additional smaller Y1 and/orY2 proteins (Fig. 4A, lanes 4–9), but
not with any of the C-terminally deleted Cmutants (Fig. 4B, lanesFig. 4. Interaction between the C mutants and Alix/AIP1. 293T cells were co-transfec
cells were radio-labeled, cell lysates were prepared, and immunoprecipitated with a
PAGE. (B) Interaction was also examined by IP-Western. At 24 h p.t., cell lysates we
were analyzed by Western blotting using anti-HA mAb to detect Alix/AIP1.2–4). These results indicate that the C-terminal 12 amino acids of
SeV C protein are important for the interaction with Alix/AIP1.
Alix/AIP1 was also co-immunoprecipitated with C-d2Y-
6KCVIM and Y1-dY2-6KCVIM, indicating that the 6KCVIMted with 5′ HA-tagged Alix/AIP1 and the indicated C mutants. (A) At 24 h p.t.,
nti-C or anti-HA antibodies. The immunoprecipitates were separated by SDS-
re prepared, and immunoprecipitated with anti-C pAb. The immunoprecipitates
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dY2 did not abolish their binding with Alix/AIP1 (Fig. 4A, lanes
10–11). In addition, C9 also interactedwithAlix/AIP1, indicating
that the Alix/AIP1-binding activity of C-d2Y-d192 was recovered
by introduction of the heterologous Alix/AIP1-binding region
(Fig. 4A, lane 12).
We next examined SeV C-Alix/AIP1-interaction by immuno-
fluorescence microscopy (Fig. 5A). 293Tcells were co-transfected
with the indicated Cmutants together with Alix/AIP1. At 24 h p.t.,
cells were stained with anti-C and anti-HA antibodies as primary
antibodies and Alexa 546-conjugated anti-rabbit IgG (red) and
Alexa 488-conjugated anti-mouse IgG (green) antibodies as
secondary antibodies, respectively. When Alix/AIP1 was ex-
pressed alone, fluorescence was observed diffusely throughout
the cytoplasm (Fig. 5A, top). In the case of the co-transfection of
Alix/AIP1-interacting C-d2Yand Alix/AIP1, C-d2Y was predom-
inantly localized at the PM, and Alix/AIP1 was now also
predominantly found and co-localized at the PM with C-d2Y
(Fig. 5A, second from the top). A similar result was observed in the
cells co-transfected with C-d2Y-6KCVIM and Alix/AIP1
(Fig. 5A, fourth from the top). In contrast, in the case of co-
transfection of Alix/AIP1-non-interacting C-d2Y-d192 and Alix/
AIP1, Alix/AIP1was still observed diffusely in the cytoplasm, and
did not co-localize at the PM, although C-d2Y-d192 was
predominantly found at the PM (Fig. 5A, third from the top). In
the case of co-transfectionwithAlix/AIP1-interactingY1-dY2 and
Alix/AIP1, no PM localization was observed for either Y1-dY2 or
Alix/AIP1, and co-localization in the cytoplasm was observed
(Fig. 5A, third from the bottom). In contrast, in the cells co-
transfected with Alix/AIP1-interacting Y1-dY2-6KCVIM or C9
and Alix/AIP1, the co-localization was now observed at the PM
and the intracellularmembranes (Fig. 5A, second and first from the
bottom).
Furthermore, we examined subcellular localization of Alix/
AIP1 in the presence of the recombinant C proteins used in Fig. 5A
by the subcellular fractionation analysis (Figs. 5B andC).Ratios of
Alix/AIP1 detected in the membrane fraction to that in the
cytosolic fraction were increased by 2–3.3-fold in the presence of
the PM-associating and Alix/AIP1-interacting C proteins, such as
C-d2Y, C-d2Y-6KCVIM, Y1-dY2-6KCVIM, and C9, compared
to that in the cells transfected with Alix/AIP1 alone, whereas the
ratios were not changed in the presence of Y1-d2Y and C-d2Y-
d192, lacking PM-association and Alix/AIP1-interaction, respec-
tively (Fig. 5C).
Together with the results described above, these results
indicate that the C proteins retaining both the ability to associate
with the PM and the ability to interact with Alix/AIP1 are able
to recruit Alix/AIP1 to the PM and to enhance SeV M-VLP
budding.
Alix/AIP1 co-localizes with SeV M protein at the PM
Since we recently reported that SeV M protein also func-
tionally interacts with Alix/AIP1 (Irie et al., 2007), interaction
of M and Alix/AIP1 was examined by immunofluorescence
microscopy (Fig. 5D). 293T cells were co-transfected with SeV
M together with Alix/AIP1 or an empty plasmid. At 24 h p.t.,cells were stained with anti-SeV and anti-HA antibodies as
primary antibodies and Alexa 546-conjugated anti-rabbit IgG
(red) and Alexa 488-conjugated anti-mouse IgG (green) anti-
bodies as secondary antibodies, respectively. When SeV M was
expressed alone, fluorescence was observed not only through-
out the cytoplasm but also at the cell periphery (Fig. 5D, top).
In the case of co-transfection of SeV M and Alix/AIP1, co-
localization of SeV M and Alix/AIP1 was observed at the cell
periphery, although both proteins were observed also at the
cytoplasm without co-localizing (Fig. 5D, bottom).
VPS4A-dependent SeV M-VLP budding requires recruitment of
Alix/AIP1 by SeV C protein
It is known that Alix/AIP1 is a component of MVB sorting
machinery (Katoh et al., 2004, 2003), and we previously re-
ported that SeV budding was sensitive to DN VPS4A expres-
sion (Sakaguchi et al., 2005). We next examined the effect of
overexpression of DN VPS4A on SeV M-VLP budding in the
presence or absence of the C mutants using a functional VLP
budding assay (Fig. 6). The expression of adequate amounts ofWT
and DN VPS4A (VPS4-WT and VPS4-EQ, respectively) and the
C mutants was confirmed in the transfected cells (Fig. 6A, lanes
43–84). In the absence of additional C proteins, budding of SeV
M-VLPwas reduced approximately 5-fold evenby overexpression
of VPS4-WT, but a further decrease was not observed in the cells
receiving VPS4-EQ (Figs. 6A, lanes 1–3, and B). Similar results
were observed in the presence of C-d2Y-d192, Y1, and Y1-d2Y,
neither of which recruited Alix/AIP1 to the PM; SeV M-VLP
buddingwas not further reduced byVPS4-EQ, compared to that in
the cells receiving VPS4-WT, although the VLP budding was
reduced even by VPS4-WT expression, compared to that in the
empty-vector-transfected cells (Figs. 6A, lanes 7–12, B, and data
not shown). In contrast, interestingly, SeV M-VLP budding was
increased approximately 2-fold by VPS4-WT expression in the
presence of C-d2Y possessing the ability to recruit Alix/AIP1 to
the PM, compared to that observed in the empty-vector-transfected
sample, and was decreased approximately 10-fold by VPS4-EQ
overexpression compared to that observed in the cells receiving
VPS4-WT (Figs. 6A, lanes 4–6, and B). Similar results were
observed in the presence of C-WT and C-d2Y-6KCVIM, which
also possess the ability to recruit Alix/AIP1 to the PM (Figs. 6A,
lanes 13–15, B, and data not shown). In addition, in the presence of
Y1-dY2-6KCVIM and C9, which were able to recruit Alix/AIP1
to the PM, budding of SeVM-VLPwas sensitive toVPS4-EQ, and
was reduced approximately 7- and 9-fold, respectively, by
overexpression of VPS4-EQ compared to that observed in the
cells receiving VPS4-WT (Figs. 6A, lanes 16–21, and B).
These results strongly suggest that SeV M-VLPs bud
through the use of cellular machinery dependent on VPS4A
activity only when Alix/AIP1 is recruited to the PM by SeV C
protein, although budding of SeV M-VLP does not seem
dependent on VPS4A in the absence of the C protein.
It should be noted that, in this experiment, M protein express-
ion in the cells was reduced by both VPS4-WT and VPS4-EQ
expression, compared to that in the empty-vector-transfected
sample, probably due to the cytotoxic effect by overexpression of
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protein expression between the empty vector- and VPS4
constructs-transfected samples might lead incorrect conclusions.However, the results in Fig. 6 were highly reproducible, and most
importantly, the difference in sensitivity of SeV M-VLP budding
to the DN VPS4 expression between in the presence and the
Fig. 5. (A) Confocal microscopy for 293T cells co-transfected with the C mutants and Alix/AIP1. At 24 h p.t., cells were stained with anti-C (red) and anti-HA (green)
antibodies. The right panels of each row represent orthogonal views of the cells reconstructed from 20 slices. Bars, 10 μm. (B) Alix/AIP1 present in the cytosolic and
membrane fractions prepared from the cells co-transfected with Alix/AIP1 with the indicated C mutants or an empty vector (−) was analyzed byWestern blotting using
anti-HA mAb. (C) Alix/AIP1 in the cytosolic and membrane fractions were quantitated as shown in Fig. 1D. Ratios of the amounts of Alix/AIP1 in the membrane
fraction to that in the cytosolic fraction were calculated and that from the cells co-transfected with the empty vector was set to 1. Bars represent the average from at least
three independent experiments. (D) Confocal microscopy for 293T cells co-transfected with SeV M and Alix/AIP1 proteins. At 24 h p.t., cells were stained with anti-
SeV (red) and anti-HA (green) antibodies.
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teins was observed, although the levels ofM protein expression in
the cells receiving VPS4-WT and VPS4-EQ were equivalent.
SeV M-VLP budding was inhibited by overexpression of DN
CHMP4B regardless of the presence or absence of the C proteins
It is known that CHMP4B (chromatin-modifying protein 4b;
charged multivesicular body protein 4b) is a component of MVB
sorting machinery and interacts with Alix/AIP1 (Katoh et al.,
2003), that CHMP4B recombinants which were N- or C-terminallyfused with fluorescent proteins, such as GFP and YFP, show DN
phenotype (Howard et al., 2001), and that the DN CHMP4B
inhibits budding of the retroviruses possessing Alix/AIP1-interact-
ing L-domain motifs (Fisher et al., 2007; von Schwedler et al.,
2003). In addition, we previously reported that both SeV M and C
proteins interact with Alix/AIP1 and that both these interactions
were important for M-VLP budding (Irie et al., 2007; Sakaguchi
et al., 2005). Finally, we examined the effect of GFP-CHMP4B
overexpression on SeVM-VLP budding in the presence or absence
of the C proteins using a functional budding assay (Fig. 7). Almost
identical amounts of M protein were expressed in transfected cells
Fig. 6. Effect of overexpression of DN VPS4A on SeV M-VLP budding in the presence or absence of the C mutants. (A) 293T cells were co-transfected with SeV M
and the indicated C mutants together with either an empty vector (−), VPS4-WT, or VPS4-EQ. At 24 h p.t., cells were radio-labeled for another 6 h. Cell lysates and
VLPs were immunoprecipitated with anti-SeV pAb for M protein, anti-C pAb for C mutants, or anti-GFP pAb for VPS4A mutants. (B) M protein present in VLPs and
cell lysates was quantitated. Budding rates were calculated as described in Materials and methods, and that from the cells receiving no VPS4 plasmids (−) was set to 1.
Bars represent the average from at least three independent experiments.
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CHMP4B was confirmed (Fig. 7, lanes 13–24). Budding of SeV
M-VLP was more than 5-fold reduced in the EGFP-CHMP4B-
transfected cells compared to that in the cells receiving the empty-
EGFP vector regardless of the presence or absence of the C proteins
(Fig. 7). This result suggests that SeVM-VLP budding is inhibited
by disruption of Alix/AIP1 activity by overexpression of EGFP-
CHMP4B regardless of the presence or absence of the C protein,
and supports the importance of Alix/AIP1 in the VLP budding.
Discussion
Our understanding of the budding of enveloped viruses has
been dramatically increased since L-domain motifs were
identified within viral matrix and retroviral Gag proteins.
Most of enveloped viruses are believed to commonly utilize
cellular MVB sorting machinery for efficient virus budding,
because the major types of L-domain motifs have been reported
to interact with cellular factors, which are known to be com-
ponents of ESCRTs and/or have been shown to have some link
to MVB sorting machinery (Bieniasz, 2006; Demirov and
Freed, 2004) and budding of retroviruses possessing any of the
major types of L-domain motifs is inhibited by overexpression
of DN forms of VPS4A (Demirov and Freed, 2004).In contrast, for many enveloped viruses, the mechanism of
efficient virus budding is still unclear, and no L-domain motifs
have been identified. For paramyxoviruses, the mechanisms of
viral and VLP budding remain to be determined, although FPIV,
YMYL, and YLDL sequences within the M proteins of SV5,
Nipah virus, and SeV, respectively, have recently been reported to
be critical for VLP budding (Ciancanelli and Basler, 2006; Irie
et al., 2007; Schmitt et al., 2005). Budding of SV5 M-VLPs is
inhibited by DNVPS4 overexpression, but the interacting partner
has not been identified yet (Schmitt et al., 2005). For Nipah virus,
both the cellular proteins interacting with the YMYL motif and
whether the MVB sorting machinery is involved in VLP budding
are unclear (Ciancanelli and Basler, 2006). We recently reported
that SeV M protein functionally interacts with Alix/AIP1 via its
YLDL motif, and that SeV budding is sensitive to DN VPS4
expression (Irie et al., 2007; Sakaguchi et al., 2005).
We previously reported that SeV was unique in that one of the
viral accessory proteins, C, enhancedM-VLP budding in a C-Alix/
AIP1-interaction-dependent manner, although SeV M protein
drives budding, like in other enveloped viruses (Irie et al., 2007;
Sakaguchi et al., 2005; Sugahara et al., 2004). Recently, C protein
was shown to associate with the PM in the experiments using an
artificial recombinant C protein in which the N-terminal 23 amino
acids and the remaining portion were separated by inserting a
Fig. 7. Effect of overexpression of EGFP-CHMP4B on SeV M-VLP budding in
the presence or absence of the C mutants. (A) 293T cells were co-transfected
with SeV M and the indicated C mutants together with either an empty EGFP
vector (−), or EGFP-CHMP4B. At 24 h p.t., cells were radio-labeled for another
6 h. Cell lysates and VLPs were immunoprecipitated with anti-SeV pAb for M
protein, anti-C pAb for C mutants, or anti-GFP pAb for EGFP-CHMP4B. (B) M
protein present in VLPs and cell lysates was quantitated. Budding rates were
calculated as described in Materials and methods, and that from the cells
receiving empty EGFP plasmid (−) was set to 1. Bars represent the average from
at least three independent experiments.
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mapped to the N-terminal 23 amino acids (Marq et al., 2007). In
this report, we show that the intact SeV C protein was able to
localize predominantly at the PM without additional smaller Y1
and/or Y2 protein expression (Fig. 1). Interestingly, however, in
the C-dY2-transfected cells where C and Y1 proteins were pro-
duced, fluorescence was observed at the nuclear envelope as well
as the PM, and in the cells transfected with C-dY1, C-dY2, and C-
d2Y lackingY2, Y1, and bothY1 andY2 expression, respectively,
more localization at intracellular membrane structures appeared
than in the C-WT-transfected cells (Fig. 1). In addition, in the Y1-
and Y1-dY2-transfected cells where Y1 and Y2, and Y1 alone
were produced, respectively, nuclear as well as cytoplasmic
localization was observed, although in the C-WT and C-dY1-
transfected cells where Y1 and/or Y2 as well as C proteins were
produced, such localization at the nuclear envelope and in the
nucleus was not observed (Fig. 1). These observations suggest that
C, Y1, and Y2 proteins may coordinate their subcellular loca-
lization with each other to play different roles in the viral life cycle.It will be of interest to determine the contributions of these
C proteins to various functions of C proteins in the viral life cycle.
We also found that the PM-associating and Alix/AIP1-
interacting C proteins were able to enhance M-VLP budding, but
the PM-non-associating and/or Alix/AIP1-non-interacting
C proteins were not (Figs. 1–4). Indeed, Alix/AIP1 was recruited
to the PMonlywhen the PM-associating andAlix/AIP1-interacting
C proteins were co-expressed, and such C proteins were able to
enhance M-VLP budding (Fig. 5). In contrast, Alix/AIP1 was
predominantly localized in the cytoplasm in the presence of the
C proteins lacking the ability of PM-association and/or Alix/AIP1-
interaction, and such C proteins failed to enhanceM-VLP budding
(Fig. 5). For example, C-d2Y-d192, retaining PM-association but
lacking Alix/AIP1-interaction, no longer recruited Alix/AIP1 to
the PMand enhancedM-VLP budding. Interestingly, this ability of
C protein to enhance M-VLP budding could be recovered by
fusing amodified CAAX domain fromK-Ras to the C-terminus of
Y1-d2Y protein, which originally retained Alix/AIP1-interaction,
but lacked PM-association (Figs. 3 and 5). In addition, the budding
enhancement was also recovered by fusing an Alix/AIP1-binding
motif-containing region fromEIAVp9Gag to theC-terminus of C-
d2Y-d192 protein, which originally retained PM-association, but
lacked Alix/AIP1-interaction (Figs. 3 and 5).
Surprisingly, M-VLP budding was not sensitive to over-
expression of DN VPS4, in the absence of any additional viral
proteins (Fig. 6), although we recently reported that M protein
functionally interacts with Alix/AIP1 (Irie et al., 2007), and that
SeV budding is reduced by DN VPS4A expression (Sakaguchi
et al., 2005). Similar observation was recently reported by
Gosselin-Grenet et al. (2007). M-VLP budding was also
insensitive to DN VPS4 when the C mutants deficient in en-
hancement ofM-VLP budding, such asC-d2Y-d192,Y1, andY1-
dY2, were co-transfected (Fig. 6). Interestingly, however,
budding of M-VLP now became sensitive to DN VPS4 express-
ion in the presence of the PM-associating and Alix/AIP1-
interacting C mutants; M-VLP budding was reduced approxi-
mately 10-fold in the case of DNVPS4 overexpression compared
to that observed in the cells receiving VPS4-WT (Fig. 6).
In addition, SeV M-VLP budding was reduced by EGFP-
CHMP4B expression regardless of the presence and the absence
of C protein expression (Fig. 7). This result supports our
previous observations that both M-Alix/AIP1 and C-Alix/AIP1-
interactions are important for efficient M-VLP budding (Irie
et al., 2007; Sakaguchi et al., 2005), because EGFP-CHMP4B
abolishes Alix/AIP1 function by direct binding, although
budding of VLPs formed by M protein alone seems to be
independent of the cellular MVB sorting function.
In sum, we propose a hypothetical model for SeV M-VLP
budding (Fig. 8). M protein itself has the ability to associate with
the inner surface of the PM and aggregates via M–M interaction
at the budding site (Fig. 8, pathway 1) (Bachi, 1980;Mottet et al.,
1996; Stricker et al., 1994). C protein is also targeted to the PM
by its own PM targeting signal (Fig. 8, pathway 4) (Marq et al.,
2007). A part of C protein recruits Alix/AIP1 to the PM by
physical interaction (Fig. 8, pathway 3) (this report). Since Alix/
AIP1 is a component of the ESCRT machinery (Katoh et al.,
2003), this machinery may also be recruited to the PM, and is
Fig. 8. Possible model for SeV M-VLP budding (see text).
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previously that M protein was also able to physically interact
with Alix/AIP1 (Irie et al., 2007), a part of M protein also
interacts with Alix/AIP1 at the PM (Figs. 8, pathway 2, and 5D).
In this model, it still remains to be determined whether C protein
recruits Alix/AIP1 to the site whereM protein aggregates andM-
VLP budding occurs. The interaction between M and C proteins
has not been reported and has not been detected Co-IP
experiments (data not shown). As described above, M protein
alone is able to bud from the cell surface in a VPS4 activity-
independent manner, although M-VLP budding is sensitive to
DNVPS4 expression, like SeV budding, in the presence of the C
proteins with the ability to recruit Alix/AIP1 to the PM. Alix/
AIP1 is not only a component of MVB sorting machinery, but
also has the ability to generate an MVB-resembling membrane
structure in vitro in the presence of a specific phospholipid,
lysobisphosphatidic acid, and to form exosomes, small mem-
brane structures that are liberated from cells (Matsuo et al., 2004;
Thery et al., 2001). Such functions of Alix/AIP1 itself may
contribute to increasing the efficiency of VLP budding formed
byM protein alone. Recently, HIV-1 Nef was reported to interact
with Alix/AIP1, resulting in the proliferation of MVBs and
enhancement of budding efficiency, in addition to the interaction
of Gag with Tsg101 and Alix/AIP1 via its PTAP and LxxL
motifs, respectively (Costa et al., 2006). Experiments to deter-
mine how Alix/AIP1 contribute to M-VLP budding in the
absence of other viral proteins are currently under way.
Finally, it seems that L-domain functions are not critical to
the budding of some viruses. For example, it has been reported
that release of recombinant VSVs and Ebola viruses whose L-
domain motifs are knocked out is reduced by 1–2 logs, but still
106–107 pfu/ml of the viruses are released into the culture
medium (Irie and Harty, 2005; Irie et al., 2005, 2004a; Jayakar
et al., 2000; Neumann et al., 2005). In addition, unlike PPxY-
type L-domain-containing retroviruses, budding of the PPxY
motif-containing rhabdoviruses and that of an Ebola VP40
mutant, VP40-dPTA, in which only the PPEY motif was
retained but the PTAP motif was abolished by deleting the first
three amino acids of the overlapping motifs, was not sensitive to
DN forms of VPS4 (Irie et al., 2004b). These observations
imply that the major budding force of the matrix protein is
provided by mechanisms other than the MVB sorting pathway,
and that the viruses utilize the cellular MVB sorting machinery
just to increase the efficiency of virus budding. For most L-domain-containing viruses, their matrix or Gag proteins possess
both of these two functions, driving budding and increasing
budding efficiency. In contrast, in the case of SeV, these
functions seem to be separated into two viral proteins M and C:
M protein drives budding and C protein increases budding
efficiency. This makes SeV a useful tool for seeking a better
understanding of envelope virus budding.
In some cases, viral L-domains and cellular MVB sorting
machinery contributed minimally in virus replication, although
critical for VLP budding. For example, a p6-deficient HIV-1
recombinant was able to be released as efficiently as a wt virus and
was not sensitive to expression of a DN form of VPS4, when an
activity of viral protease was abolished by introducing a specific
amino acid change or adding a specific inhibitor (Fang et al.,
2007). For SeV, in contrast to our observations in the SeVM-VLP
system (Irie et al., 2007; Sakaguchi et al., 2005), neither expression
of DN VPS4 nor depletion of Alix/AIP1 largely affected virus
replication (Gosselin-Grenet et al., 2007). In addition, inhibition of
C protein expression by a siRNA technique did not affect the
recombinant SeV lacking expression of C proteins from P mRNA
but expressing GFP-fused C protein from an additional cistron.
However, we previously reported that SeV budding from the cells
transfected with purified SeV nucleocapsid is sensitive to DN
VPS4 (Sakaguchi et al., 2005), and we found that knock-out of C'
and C protein expression from P mRNA resulted in reduced SeV
budding (data not shown). Such discrepancies might be due to the
difference in experimental system used, and these observations
suggest that virus budding is a more complicated event especially
than VLP budding, and that more viral and cellular factors
involved in virus budding are still unidentified.
Materials and methods
Cells and antibodies
Human 293T cells were maintained in Dulbecco's minimum
essential medium (DMEM; Sigma) supplemented with 10% fetal
bovine serum (FBS; Biological Industries, Kibbutz Beit Haemek,
Israel) and penicillin–streptomycin (Invitrogen) at 37 °C. Poly-
clonal antibodies (pAb) against the whole virion of SeV was
described previously (Sugahara et al., 2004). pAb against SeV C
protein was kindly provided by A. Kato (National Institute for
Infectious Diseases, Japan). pAb against green fluorescent protein
(GFP) (sc-8334; Santa Cruz biotechnology, Santa Cruz, CA) and
monoclonal antibody (mAb) against HA-tag (HA.C5; GeneTex,
San Antonio, TX) were used according to the protocols of the
suppliers.
Plasmid construction
Plasmids encoding SeV C-WT, SeV HN, and 5′ HA-tagged
AIP1-WT in pCAGGS.MCS vector and a plasmid encoding SeV
Y2 in pKS vector have been described previously (Sakaguchi et
al., 2005; Sugahara et al., 2004). C gene mutants (C-dY1, C-dY2,
C-d2Y, C-d2Y-d192, C-d2Y-d188,C-d2Y-d184, Y1, andY1-dY2)
and the other mutants [C-d2Y-6KCVIM, Y1-dY2-6KCVIM, Y1-
dY2-12KCVIM, Y1-dY2-6(KR)CVIM, and C9] were generated
119T. Irie et al. / Virology 371 (2008) 108–120by introducing point-mutations using a QuickChange XL site-
directed mutagenesis kit (Stratagene) and using a standard PCR
technique, respectively, and inserted into the pCAGGS.MCS
vector. The full-length cDNA clone of human CHMP4B (DDBJ/
EMBL/GenBank accession number BC033859) was obtained
from Open Biosystems and subcloned into pEGFP-C1 vector
(Clontech). All of these constructs were confirmed by DNA
sequencing. Plasmids encoding EGFP-fused VPS4A-WT and a
DNmutantVPS4A-E228Qwere kindly provided byW. Sundquist
(University of Utah).
Immunofluorescence microscopy
Human 293T cells cultured in 6-well plates containing glass
coverslips were transfected with the indicated plasmids using the
FuGENE HD transfection reagent (Roche Diagnostics). At 24 h
post-transfection (p.t.), cells were fixed with 3% formaldehyde
solution, and then treated with 0.1% Triton X-100 in phosphate-
buffered saline (PBS). Cells were then stained using anti-C pAb
or anti-SeV pAb, and/or anti-HA mAb as primary antibodies
and Alexa 488- or Alexa 546-conjugated anti-rabbit IgG goat
pAb and/or Alexa 488-conjugated anti-mouse IgG goat pAb
(Invitrogen) as secondary antibodies, respectively. Coverslips
were mounted on glass slides and observed using a Zeiss LSM 5
confocal microscope (Carl Zeiss).
Subcellular fractionation
293T cells cultured in 10 cm dishes were transfected with the
indicated plasmids using the FuGENE HD reagent. At 24 h p.t.,
subcellular fractions were prepared as described previously by
Welman et al. (2000). Briefly, cells were washed with ice-cold
PBS, resuspended in 1 ml of ice-cold hypotonic buffer (10 mM
HEPES [pH 7.5], 10 mM NaCl, 1 mM MgCl2, 1 mM CaCl2,
1 mM KCl) containing “Complete” protease inhibitor cocktail
(Roche Diagnostics), incubated on ice for 15 min, and homo-
genized by 25 passages through a 25G5/8 (0.5×16) needle.
After centrifugation for 5 min at 500×g, postnuclear supernatant
(PNS) was centrifuged for 30 min at 120,000×g. The pellet
(membrane fraction) was suspended in 100 μl of SDS-PAGE
sample buffer (125 mM Tris–HCl [pH 6.8], 4.6% sodium
dodecyl sulfate [SDS], 5% 2-mercaptoethanol, 0.005% bromo-
phenol blue, 20% glycerol). The supernatant (soluble fraction)
was subjected to acetone precipitation, and the protein pellet
was suspended in 100 μl of SDS-PAGE sample buffer. Equal
volumes of each fraction sample were analyzed by 12% SDS-
PAGE followed by Western blotting using anti-SeV pAb, anti-C
pAb, or anti-HA mAb. Protein bands were detected by a
chemiluminescent method using an ECL plus Western blotting
detection reagent (GE Healthcare Life Sciences), and analyzed
using an LAS-1000 luminescent image analyzer (Fuji Film).
Functional VLP budding assay
293T cells cultured in 6-well plates were transfected with the
indicated plasmids using the FuGENE HD reagent. At 24 h p.t.,
cellsweremetabolically labeledwith 3.7MBq/ml of [35S]Met-Cys(Pro-mix; GE Healthcare Life Sciences) for 6 h. Culture medium
was harvested and clarified at 3,000 rpm for 10 min. The
supernatant was then centrifuged at 40,000 rpm for 2 h through a
20% sucrose cushion. The pellet was suspended in radio-
immunoprecipitation assay (RIPA) buffer (1% Triton X-100, 1%
sodium deoxycholate, 0.1% SDS, 10 mM Tris–HCl [pH 7.4],
150 mM NaCl) containing a “Complete” protease inhibitor
cocktail, immunoprecipitated with anti-SeV pAb, and analyzed
by SDS-PAGE. In order to examine the protein expression from
transfected plasmids, cell lysates were also immunoprecipitated
with the appropriate antibodies, and analyzed by SDS-PAGE.
Protein bands were visualized and quantitated with a BAS2000
Bio-imaging analyzer (Fuji Film). VLP budding rate was
calculated as the ratio of M protein in VLPs to that in cell lysates.
Samples from the cells transfected with an empty pCAGGS.MCS
vector were used as the background control.
Co-IP
293T cells cultured in 6-well plates were co-transfected with
the indicated plasmids using the FuGENE HD reagent, and
metabolically labeled with [35S]Met-Cys as described above.
Cells were then suspended in cell lysis buffer (0.5% NP-40,
20 mM Tris–HCl [pH 7.4], 150 mM NaCl) containing a
“Complete” protease inhibitor cocktail. Cell lysate samples
were immunoprecipitated with either anti-C or -HA antibody.
The immunoprecipitates were separated by SDS-PAGE, and
analyzed with a BAS2000 Bio-imaging analyzer.
IP-Western
293Tcells cultured in 6-well plates were co-transfectedwith the
indicated plasmids using the FuGENE HD reagent. At 24 h p.t.,
cells were suspended in cell lysis buffer as described above. Cell
lysate samples were immunoprecipitated with anti-C pAb, and the
immunoprecipitates were separated by SDS-PAGE followed by
Western blotting using anti-HA mAb to detect co-immunopreci-
pitated HA-tagged Alix/AIP1. Cell lysates were also subjected
directly to Western blotting using anti-C or anti-HA antibody to
confirm the expression of C mutants and Alix/AIP1, respectively.
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